HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (345)	3/1/2002 7:28:27 AM
From: tom pope	Read Replies (1) of 1022

And it's not getting any better today, Nigel, at least not yet. Both PDLI and ABGX traded well under their closing prices in After Hours, PDLI in reaction to this: PDLI Protein Design matches consensus; warns for FY02 (15.87 -0.30) Posts a Q4 loss of $0.06 a share, in line with consensus, vs yr ago EPS of $0.00. Revenues declined 14.8% to $15 mln. For fiscal yr 2002, co expects a loss in the range of $0.17-$0.26 (consensus +0.02). "Although we do not believe we will be profitable in 2002, we want to emphasize that the major change from 2001 is a decline in interest rates, not a change in our core business operations or strategy."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next